These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 31434931)
21. Characterization of MEDLE-1, a protein in early development of Cryptosporidium parvum. Fei J; Wu H; Su J; Jin C; Li N; Guo Y; Feng Y; Xiao L Parasit Vectors; 2018 May; 11(1):312. PubMed ID: 29792229 [TBL] [Abstract][Full Text] [Related]
24. Cryptosporidium excystation and invasion: getting to the guts of the matter. Smith HV; Nichols RA; Grimason AM Trends Parasitol; 2005 Mar; 21(3):133-42. PubMed ID: 15734661 [TBL] [Abstract][Full Text] [Related]
25. Novel Bioengineered Three-Dimensional Human Intestinal Model for Long-Term Infection of Cryptosporidium parvum. DeCicco RePass MA; Chen Y; Lin Y; Zhou W; Kaplan DL; Ward HD Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28052996 [No Abstract] [Full Text] [Related]
26. The Cryptosporidium signaling kinase CDPK5 plays an important role in male gametogenesis and parasite virulence. Nava MG; Szewczyk J; Arrington JV; Alam T; Vinayak S Cell Rep; 2024 Jun; 43(6):114263. PubMed ID: 38814783 [TBL] [Abstract][Full Text] [Related]
27. Prodrug activation by Cryptosporidium thymidine kinase. Sun XE; Sharling L; Muthalagi M; Mudeppa DG; Pankiewicz KW; Felczak K; Rathod PK; Mead J; Striepen B; Hedstrom L J Biol Chem; 2010 May; 285(21):15916-22. PubMed ID: 20231284 [TBL] [Abstract][Full Text] [Related]
28. The immunological selection of recombinant peptides from Cryptosporidium parvum reveals 14 proteins expressed at the sporozoite stage, 7 of which are conserved in other apicomplexa. Trasarti E; Pizzi E; Pozio E; Tosini F Mol Biochem Parasitol; 2007 Apr; 152(2):159-69. PubMed ID: 17267054 [TBL] [Abstract][Full Text] [Related]
29. Paromomycin inhibits Cryptosporidium infection of a human enterocyte cell line. Marshall RJ; Flanigan TP J Infect Dis; 1992 Apr; 165(4):772-4. PubMed ID: 1552210 [TBL] [Abstract][Full Text] [Related]
30. Development of a Cytopathic Effect-Based Phenotypic Screening Assay against Cryptosporidium. Chao AT; Lee BH; Wan KF; Selva J; Zou B; Gedeck P; Beer DJ; Diagana TT; Bonamy GMC; Manjunatha UH ACS Infect Dis; 2018 Apr; 4(4):635-645. PubMed ID: 29341586 [TBL] [Abstract][Full Text] [Related]
31. A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice. Castellanos-Gonzalez A; Sparks H; Nava S; Huang W; Zhang Z; Rivas K; Hulverson MA; Barrett LK; Ojo KK; Fan E; Van Voorhis WC; White AC J Infect Dis; 2016 Dec; 214(12):1850-1855. PubMed ID: 27738055 [TBL] [Abstract][Full Text] [Related]
32. Labeling surface epitopes to identify Cryptosporidium life stages using a scanning electron microscopy-based immunogold approach. Edwards H; Thompson RC; Koh WH; Clode PL Mol Cell Probes; 2012 Feb; 26(1):21-8. PubMed ID: 22100878 [TBL] [Abstract][Full Text] [Related]
33. RNA-Seq analysis during the life cycle of Cryptosporidium parvum reveals significant differential gene expression between proliferating stages in the intestine and infectious sporozoites. Lippuner C; Ramakrishnan C; Basso WU; Schmid MW; Okoniewski M; Smith NC; Hässig M; Deplazes P; Hehl AB Int J Parasitol; 2018 May; 48(6):413-422. PubMed ID: 29432770 [TBL] [Abstract][Full Text] [Related]
34. Modulation of gene expression of three Cryptosporidium parvum ATP-binding cassette transporters in response to drug treatment. Benitez AJ; McNair N; Mead J Parasitol Res; 2007 Nov; 101(6):1611-6. PubMed ID: 17705063 [TBL] [Abstract][Full Text] [Related]
35. Immunolocation and enzyme activity analysis of Cryptosporidium parvum enolase. Mi R; Yang X; Huang Y; Cheng L; Lu K; Han X; Chen Z Parasit Vectors; 2017 May; 10(1):273. PubMed ID: 28569179 [TBL] [Abstract][Full Text] [Related]
36. Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity. Zhang X; Kim CY; Worthen T; Witola WH Int J Parasitol; 2018 Jul; 48(8):649-656. PubMed ID: 29530646 [TBL] [Abstract][Full Text] [Related]
37. Molecular characterisation of Cryptosporidium isolates from humans in Slovenia. Soba B; Petrovec M; Mioc V; Logar J Clin Microbiol Infect; 2006 Sep; 12(9):918-21. PubMed ID: 16882299 [TBL] [Abstract][Full Text] [Related]
38. First report of Cryptosporidium parvum in a dromedary camel calf from Western Australia. Zahedi A; Lee GKC; Greay TL; Walsh AL; Blignaut DJC; Ryan UM Acta Parasitol; 2018 Jun; 63(2):422-427. PubMed ID: 29654683 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice. Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052 [TBL] [Abstract][Full Text] [Related]
40. Validation of cell-free culture using scanning electron microscopy (SEM) and gene expression studies. Yang R; Elankumaran Y; Hijjawi N; Ryan U Exp Parasitol; 2015 Jun; 153():55-62. PubMed ID: 25765560 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]